Enanta Pharmaceuticals (ENTA) Change in Account Payables (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Change in Account Payables of $2.5 million for Q1 2026, up 4033.33% on a QoQ basis from -$63000.0 in Q4 2025, and up 183.85% year-over-year from $873000.0 in Q1 2025.
Enanta Pharmaceuticals (ENTA) Change in Account Payables (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals' Change in Account Payables history runs 15 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- Quarterly Change in Account Payables rose 183.85% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $399000.0 (up 1230.0% YoY) and the FY2025 annual result came in at -$1.3 million, down 216.67% from the prior year.
- Change in Account Payables was $2.5 million for Q1 2026 at Enanta Pharmaceuticals, up from -$63000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.6 million in Q1 2023 and bottomed at -$5.1 million in Q2 2022.
- A 5-year average of -$201882.4 and a median of -$686000.0 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables slumped 2923.33% — and 2023, when it jumped 854.23%.
- Enanta Pharmaceuticals' Change in Account Payables stood at -$686000.0 in 2022, then soared by 854.23% to $5.2 million in 2023, then tumbled by 103.25% to -$168000.0 in 2024, then soared by 62.5% to -$63000.0 in 2025, then soared by 4033.33% to $2.5 million in 2026.
- Business Quant data shows ENTA's Change in Account Payables at $2.5 million in Q1 2026, -$63000.0 in Q4 2025, and -$723000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - | 2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.48 Mn |
| Mar 31, 2026 | 2.48 Mn |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -723,000.00 |
| Sep 30, 2025 | -723,000.00 |
| Jun 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -1.29 Mn |
| Mar 31, 2025 | 873,000.00 |
| Mar 31, 2025 | 873,000.00 |
| Dec 31, 2024 | -168,000.00 |
| Dec 31, 2024 | -168,000.00 |
| Sep 30, 2024 | -1.54 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | 863,000.00 |
| Jun 30, 2024 | 863,000.00 |
| Mar 31, 2024 | -4.91 Mn |
| Mar 31, 2024 | -4.91 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Dec 31, 2023 | 5.17 Mn |